A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.

Source:http://linkedlifedata.com/resource/pubmed/id/19874925

Vaccine 2009 Dec 9 27 52 7292-8

Download in:

View as

Triples

General Info

PMID
19874925